|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/48 | |
| A61K 9/107 | |||
| A61K 9/14 | |||
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61K 9/50 | |||
| A61K 31/505 |
| (11) | Patento numeris | 1567134 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03789453.2 |
| Europos patento paraiškos padavimo data | 2003-11-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-08-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2003/050890 |
| Data | 2003-11-25 |
| (87) | Numeris | WO 2004/050058 |
| Data | 2004-06-17 |
| (30) | Numeris | Data | Šalis |
| PCT/EP02/13558 | 2002-11-29 | WO |
| (72) |
VANDECRUYS, Roger, Petrus, Gerebern, BE
PEETERS, Jozef, BE
BREWSTER, Marcus, Eli, BE
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | Pharmaceutical compositions comprising a basic drug compound, vitamin E TPGS and a physiologically tolerable water-soluble acid |
| Pharmaceutical compositions comprising a basic drug compound, vitamin E TPGS and a physiologically tolerable water-soluble acid |